Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey.
Prostaglandins Other Lipid Mediat. 2013 Apr-May;102-103:31-41. doi: 10.1016/j.prostaglandins.2013.01.005. Epub 2013 Feb 27.
We have previously demonstrated that a stable synthetic analog of 20-HETE, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine (5,14-HEDGE), restores vascular reactivity, blood pressure, and heart rate in endotoxemic rats. The aim of this study was to determine whether decreased renal expression and activity of soluble epoxide hydrolase (sEH), MEK1, ERK1/2, IKKβ, IκB-α, and NF-κB as well as systemic and renal proinflammatory cytokine production associated with increased expression and activity of CYP2C23 contributes to the effect of 5,14-HEDGE to prevent hypotension, tachycardia, inflammation, and mortality in response to systemic administration of lipopolysaccharide (LPS). Blood pressure fell by 33 mmHg and heart rate rose by 57 beats/min in LPS (10 mg/kg, i.p.)-treated rats. Administration of LPS also increased mRNA and protein expression of sEH associated with a decrease in CYP2C23 mRNA and protein expression. Increased activity of sEH and p-MEK1, p-ERK1/2, p-IκB-α, NF-κB, and p-NF-κB protein levels as well as TNF-α and IL-8 production by LPS were also associated with a decreased activity of AA epoxygenases. These effects of LPS were prevented by 5,14-HEDGE (30 mg/kg, s.c.; 1 h after LPS). Treatment of endotoxemic mice with 5,14-HEDGE also raised the survival rate of animals from 84% to 98%. A competitive antagonist of vasoconstrictor effects of 20-HETE, 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid, 20-HEDE (30 mg/kg, s.c.; 1 h after LPS) prevented the effects of 5,14-HEDGE on blood pressure, heart rate, expression and/or activity of sEH, CYP2C23, and ERK1/2 as well as TNF-α and IL-8 levels in rats treated with LPS. These results suggest that decreased expression and/or activity of sEH and MEK1/ERK1/2/IKKβ/IκB-α/NF-κB pathway as well as proinflammatory cytokine production associated with increased CYP2C23 expression and antiinflammatory mediator formation participate in the protective effect of 5,14-HEDGE against hypotension, tachycardia, inflammation, and mortality in the rodent model of septic shock.
我们之前的研究表明,20-HETE 的稳定合成类似物 N-[20-羟基二十碳-5(Z),14(Z)-二烯酰]甘氨酸(5,14-HEDGE)可恢复内毒素血症大鼠的血管反应性、血压和心率。本研究旨在确定肾组织中可溶性环氧化物水解酶(sEH)、MEK1、ERK1/2、IKKβ、IκB-α 和 NF-κB 的表达和活性降低,以及全身和肾脏促炎细胞因子产生与 CYP2C23 表达和活性增加是否有助于 5,14-HEDGE 预防低血压、心动过速、炎症和死亡率的作用,以应对全身给予脂多糖(LPS)。给予 LPS(10mg/kg,腹腔注射)后,大鼠血压下降 33mmHg,心率升高 57 次/分钟。给予 LPS 还增加了 sEH 的 mRNA 和蛋白表达,同时降低了 CYP2C23 的 mRNA 和蛋白表达。LPS 还增加了 sEH 的活性以及 p-MEK1、p-ERK1/2、p-IκB-α、NF-κB 和 p-NF-κB 蛋白水平,以及 TNF-α 和 IL-8 的产生,这与 AA 环氧化酶的活性降低有关。5,14-HEDGE(30mg/kg,皮下注射;在 LPS 后 1 小时)可预防 LPS 的这些作用。给予内毒素血症小鼠 5,14-HEDGE 治疗还将动物的存活率从 84%提高到 98%。20-HETE 血管收缩作用的竞争性拮抗剂 20-羟基二十碳-6(Z),15(Z)-二烯酸,20-HEDE(30mg/kg,皮下注射;在 LPS 后 1 小时)可预防 5,14-HEDGE 对 LPS 处理大鼠的血压、心率、sEH、CYP2C23 和 ERK1/2 的表达和/或活性以及 TNF-α 和 IL-8 水平的影响。这些结果表明,sEH 和 MEK1/ERK1/2/IKKβ/IκB-α/NF-κB 途径的表达和/或活性降低以及与 CYP2C23 表达增加和抗炎介质形成相关的促炎细胞因子产生参与了 5,14-HEDGE 对败血症休克啮齿动物模型中低血压、心动过速、炎症和死亡率的保护作用。